Argonaut Therapeutics
Latest round
- Seed
Last raised
- Oct 2016
Total raised
- Undisclosed
Investors
- 1
About Argonaut Therapeutics
Founded in 2016 and based in Oxford, UK, Argonaut Therapeutics Limited operates as a biotechnology company that conducts research and development of new cancer drugs. In January 2023, Celleron Therapeutics Limited, a portfolio company of WOORI Venture Partners, Korea Investment Partners, NHN Investment, and IMM Investment, merged with Argonaut Therapeutics Limited to form IngenOx Therapeutics Limited. Argonaut Therapeutics specializes in developing novel epigenetic therapies targeting abnormal arginine methylation. Argonaut’s lead programs focus on inhibitors of protein arginine methyltransferase 5 (PRMT5), aiming to restore natural cell death mechanisms in malignant cells. Leveraging its proprietary platforms, EXACT™ and ADEPT™, the company developed drug candidates such as AT101, which entered Phase I trials for solid tumors.
Who invested in Argonaut Therapeutics
1 investor across 1 round
See all investors in Argonaut Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Seed
Oct 19, 2016
Amount
Undisclosed
Investors
Questions about Argonaut Therapeutics
Who invested in Argonaut Therapeutics?
Argonaut Therapeutics has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Argonaut Therapeutics raised?
Argonaut Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Argonaut Therapeutics last raise money?
Argonaut Therapeutics's most recent round on record is a Seed, in Oct 2016.
What does Argonaut Therapeutics do?
Founded in 2016 and based in Oxford, UK, Argonaut Therapeutics Limited operates as a biotechnology company that conducts research and development of new cancer drugs.
Where is Argonaut Therapeutics headquartered?
Argonaut Therapeutics is headquartered in Oxford, UK.
Which VCs invest in companies like Argonaut Therapeutics?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Balderton Capital back biotechnology companies at Argonaut Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Seed
Raising like Argonaut Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.